T
LLY icon

Tableaux’s Eli Lilly LLY Stock Holding History

Tableaux’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$211K Sell
229
-41
-15% -$41.6K 0.1% 108
2025
Q4 		$290K Sell
270
-644
-70% -$616K 0.21% 68
2025
Q3 		$697K Buy
914
+457
+100% +$340K 0.28% 50
2025
Q2 		$356K Hold
457
– – 0.2% 85
2025
Q1 		$377K Buy
457
+23
+5% +$19.1K 0.27% 57
2024
Q4 		$335K Buy
+434
New +$359K 0.28% 49

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Tableaux's LLY Position: Q1 2026 in Review

Tableaux reduced its Eli Lilly (LLY) stake by 15% in Q1 2026, selling an estimated $41.6K and leaving 229 shares worth $211K. The position accounts for 0.1% of the portfolio, ranked #108.

Tableaux first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $697K in Q3 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Tableaux held 229 shares of Eli Lilly worth $211K as of Q1 2026.
  • Tableaux sold 41 Eli Lilly shares in Q1 2026, an estimated $41.6K.
  • Eli Lilly made up 0.1% of Tableaux's portfolio in Q1 2026, its #108 holding.
  • Tableaux first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Tableaux's Eli Lilly position peaked at $697K in Q3 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Tableaux's 13F filing for Q1 2026, filed 14 May 2026.